OKYO Pharma Limited

NASDAQ: OKYO · Real-Time Price · USD
2.73
0.09 (3.41%)
At close: Aug 15, 2025, 11:24 AM

OKYO Pharma Income Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
7.51K 3.8K 2.42K 13.09K
Gross Profit
-7.51K -3.8K -2.42K -13.09K
Operating Income
-15.75K -13.19M -6.23M -4.13M
Interest Income
n/a n/a n/a n/a
Pretax Income
-16.8M -13.28M -6.22M -3.38M
Net Income
-16.83K -13.27M -5.43M -3.35M
Selling & General & Admin
7.45M 6.75M 4.93M 2.97M
Research & Development
8.24K 6.34M 1.61M 348.35K
Other Expenses
n/a n/a n/a n/a
Operating Expenses
8.24K 13.19M 6.22M 3.37M
Interest Expense
n/a 96.69K n/a 1.12K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
15.75K 13.19M 6.22M 3.37M
Income Tax Expense
22.42 -12.2K -787K -24.99K
Shares Outstanding (Basic)
29.34M 22.26M 15.06M 10.35M
Shares Outstanding (Diluted)
29.34M 22.26M 15.06M 10.35M
EPS (Basic)
-0.00 -0.6 -0.36 -0.32
EPS (Diluted)
-0.00 -0.6 -0.36 -0.32
EBITDA
-15.75K -13.18M -6.21M -3.35M
EBIT
-15.75K -13.19M -6.22M -3.37M
Depreciation & Amortization
3.87K 3.8K 2.33K 13.11K